Elden Ring Tarnished Edition Lands Friday — Here’s When You Can Start Playing

Elden Ring Tarnished Edition lands Friday on Switch 2. No publisher has posted an unlock hour. Here is what is known, plus price, file size and review scores.

NYT Strands Answers Today: Hints & Clues For Thursday, August 27 (Spiraling Definitions)

Looking for help with today’s NYT Strands puzzle? Here’s an extra hint to help you uncover the right words, as well as all of today’s answers and Spangram.

School Phone Bans Are Increasing Across America—Here’s What The Science Says On Their Effects On Mental Health

More states are adopting cellphone bans in schools. A doctor breaks down the science on how these interventions can affect a child’s mental health.

Tom Aspinall’s Next Fight: 3 Eye Surgeries, 10 Months, Beef With Dana White: What We Know

Tom Aspinall shut down UFC exit rumors on Wednesday. Where his eye injury stands, why the Dana White fallout started and who he fights next at heavyweight.

OpenAI Finds Agents That Breached Hugging Face Were ‘Reward Hacking’

OpenAI released a report on the Hugging Face noting that its AI agents are prone to reward hacking, and gaming cybersecurity evaluations.

Bill Gates Is Wrong About The Remedy

Bill Gates is wrong to think that the answer to AI’s growing power is to build institutions capable of governing it.

Eyeing Expansion Into Wealth Management, Vanguard Buys Fintech Altruist For As Much As $5 Billion

The acquisition is only the second ever for the 51-year-old company as it tries to expand beyond index-fund fees.

Former Champion Takes Heavyweight Title Fight On 12-Hours Notice

BKB 58 date and start time after a late main event change. Mick Terrill steps in for Mark O’Neil against Gustavo Trujillo for the heavyweight title in Miami.

Why Kimberly-Clark’s CIO Says Operating Models Matter More Than AI

Kimberly-Clark’s Chief Information and GBS Officer on why lasting transformation starts with people and process.

FDA Approves New Pancreatic Cancer Drug After Stunning Trial Results

The therapy is a brand new targeted drug for the disease which experts have labelled as a substantial breakthrough following doubling of survival time in a trial.